Using Amorphous Spray-Dried Dispersions to Develop Oral Solid Dosage Forms

This webinar describes the development of oral solid dosage forms from amorphous spray-dried dispersions, an enabling technology for the delivery of low-solubility drugs. Process considerations and results are presented for different oral dosage forms, including immediate- and modified-release tablets. Given the platform nature of the technology, dosage-form development is streamlined and efficient, requiring minimal API and time, and resulting in seamless scale-up to clinical-trial, pilot, and commercial settings.